Hélène Morin

479 total citations
20 papers, 278 citations indexed

About

Hélène Morin is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Hélène Morin has authored 20 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Hélène Morin's work include Prostate Cancer Treatment and Research (11 papers), Estrogen and related hormone effects (9 papers) and Hormonal and reproductive studies (5 papers). Hélène Morin is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Estrogen and related hormone effects (9 papers) and Hormonal and reproductive studies (5 papers). Hélène Morin collaborates with scholars based in Canada, France and United Kingdom. Hélène Morin's co-authors include Artem Cherkasov, Eric Leblanc, Nada Lallous, Paul S. Rennie, Fuqiang Ban, Joseph Lee, Fariba Ghaidi, Martin Gleave, Kush Dalal and Ashley Shepherd and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Hélène Morin

20 papers receiving 272 citations

Peers

Hélène Morin
Mohamed D.H. Hassona United States
Aihua Edward Yen United States
Jacky K. Leung Canada
Aashvini Belosay United States
Alicja Puszkiel France
Andrew K. Kwegyir‐Afful United States
Verónica Rodríguez Italy
Senthilmurugan Ramalingam United States
Maysoun Shomali United States
Helen R. Kim United States
Mohamed D.H. Hassona United States
Hélène Morin
Citations per year, relative to Hélène Morin Hélène Morin (= 1×) peers Mohamed D.H. Hassona

Countries citing papers authored by Hélène Morin

Since Specialization
Citations

This map shows the geographic impact of Hélène Morin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Morin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Morin more than expected).

Fields of papers citing papers by Hélène Morin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Morin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Morin. The network helps show where Hélène Morin may publish in the future.

Co-authorship network of co-authors of Hélène Morin

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Morin. A scholar is included among the top collaborators of Hélène Morin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Morin. Hélène Morin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foo, Jane, Francesco Gentile, Hélène Morin, et al.. (2024). Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2). Breast Cancer Research. 26(1). 168–168. 3 indexed citations
2.
Morin, Hélène, Mohit Pandey, Fuqiang Ban, et al.. (2023). Novel Inhibitors of androgen receptor's DNA binding domain identified using an ultra‐large virtual screening. Molecular Informatics. 42(8-9). e2300026–e2300026. 7 indexed citations
3.
Li, Huifang, Eric Leblanc, Kush Dalal, et al.. (2022). Structure-Based Study to Overcome Cross-Reactivity of Novel Androgen Receptor Inhibitors. Cells. 11(18). 2785–2785. 5 indexed citations
4.
Ton, Anh‐Tien, Jane Foo, Kriti Singh, et al.. (2022). Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer. International Journal of Molecular Sciences. 23(5). 2588–2588. 10 indexed citations
5.
Foucher, Yohann, Vincent Letocart, Thibaut Manigold, et al.. (2021). Carotid versus femoral access for transcatheter aortic valve replacement: comparable results in the current era. European Journal of Cardio-Thoracic Surgery. 60(4). 874–879. 7 indexed citations
6.
Lallous, Nada, C. Antonio Sánchez, Bei Sun, et al.. (2021). Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients. Cancers. 13(12). 2939–2939. 19 indexed citations
7.
Bailly, Arthur, François Roux, Hélène Morin, et al.. (2021). Evaluation of the impact of HMS Plus on postoperative blood loss compared with ACT Plus in cardiac surgery. Minerva Anestesiologica. 87(11). 1191–1199. 2 indexed citations
8.
Ban, Fuqiang, Eric Leblanc, Chia-Chi Flora Huang, et al.. (2021). Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer. Cancers. 13(14). 3488–3488. 20 indexed citations
9.
10.
Ton, Anh‐Tien, Hélène Morin, Fuqiang Ban, et al.. (2020). Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer. International Journal of Molecular Sciences. 21(21). 8277–8277. 20 indexed citations
11.
Leblanc, Eric, Nada Lallous, Hélène Morin, et al.. (2019). Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer. Molecules. 24(4). 763–763. 34 indexed citations
12.
Dalal, Kush, Hélène Morin, Fuqiang Ban, et al.. (2018). Small molecule-induced degradation of the full length and V7 truncated variant forms of human androgen receptor. European Journal of Medicinal Chemistry. 157. 1164–1173. 14 indexed citations
13.
Lallous, Nada, Eric Leblanc, Fuqiang Ban, et al.. (2018). Computer-aided drug discovery of Myc-Max inhibitors as potential therapeutics for prostate cancer. European Journal of Medicinal Chemistry. 160. 108–119. 38 indexed citations
14.
Dalal, Kush, Fuqiang Ban, Huifang Li, et al.. (2018). Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer. Cancer Letters. 437. 35–43. 45 indexed citations
15.
Ban, Fuqiang, Kush Dalal, Eric Leblanc, et al.. (2018). Cheminformatics Driven Development of Novel Therapies for Drug Resistant Prostate Cancer. Molecular Informatics. 37(9-10). e1800043–e1800043. 6 indexed citations
16.
Lallous, Nada, Eric Leblanc, Mohamed D.H. Hassona, et al.. (2016). Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation. Molecular Cancer Therapeutics. 15(12). 2936–2945. 25 indexed citations
17.
Dalal, Kush, et al.. (2016). Drug-Discovery Pipeline for Novel Inhibitors of the Androgen Receptor. Methods in molecular biology. 1443. 31–54. 5 indexed citations
18.
MIOCQUE, M., et al.. (1973). [Farnesol, psychosedative and spasmolytic drug].. PubMed. 27(5). 893–905. 5 indexed citations
19.
Morin, Hélène, et al.. (1955). [Pharmacodynamic study of tabersonine, an alkaloid extracted from the seeds of Amsonia tabernaemontana Walt. (Apocyanaceae)].. PubMed. 13(2). 123–6. 1 indexed citations
20.
Morin, Hélène, et al.. (1953). [Pharmacometry of the main soluble theophylline derivatives].. PubMed. 61(73). 1480–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed D.H. Hassona Breakdown of academic impact, for papers by Aihua Edward Yen Breakdown of academic impact, for papers by Jacky K. Leung Breakdown of academic impact, for papers by Aashvini Belosay Breakdown of academic impact, for papers by Alicja Puszkiel Breakdown of academic impact, for papers by Andrew K. Kwegyir‐Afful Breakdown of academic impact, for papers by Verónica Rodríguez Breakdown of academic impact, for papers by Senthilmurugan Ramalingam Breakdown of academic impact, for papers by Maysoun Shomali Breakdown of academic impact, for papers by Helen R. Kim
Rankless by CCL
2026